Long-lasting physiological antagonism of calcitonin gene-related peptide towards endothelin-1 in rat mesenteric arteries and human coronary arteries

被引:9
作者
Labruijere, Sieneke [1 ]
Compeer, Matthijs G. [4 ]
van den Bogaerdt, Antoon J. [2 ,3 ]
van den Brink, Antoinette Maassen [1 ]
De Mey, Jo G. R. [4 ]
Danser, A. H. Jan [1 ]
Batenburg, Wendy W. [1 ]
机构
[1] Erasmus MC, Div Pharmacol & Vasc Med, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands
[2] Erasmus MC, Dept Thorac Surg, NL-3015 GE Rotterdam, Netherlands
[3] Erasmus MC, Heart Valve Bank, NL-3015 GE Rotterdam, Netherlands
[4] Maastricht Univ, Dept Pharmacol, Maastricht, Netherlands
关键词
Endothelin-1; Calcitonin-gene related peptide; BQ123; Rat mesenteric artery; Human coronary artery; SIGNAL-TRANSDUCTION; ANGIOTENSIN-II; ETA-RECEPTOR; MICROARTERIES; PHARMACOLOGY;
D O I
10.1016/j.ejphar.2013.10.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Endothelin-1 causes long-lasting contraction via endothelin type A receptor (ETAR) in isolated rat mesenteric arteries (RMA) that cannot be readily terminated by removing the agonist, or by adding the ETAR antagonist BQ123 or the NO donor sodium nitroprusside. It could be terminated by adding calcitonin-gene related peptide (CGRP), most likely because CGRP causes ET-/ETAR dissociation. Here we investigated this phenomenon in human coronary microarteries (HCMA). We simultaneously verified the effects of CGRP in RMA and HCMA towards other vasoconstrictors, i.e., the alpha(1)-adrenoceptor agonist phenylephrine, the thromboxane A(2) analog U46619 (9,11-dideoxy-11 alpha,9 alpha-epoxy-methano-prostaglandin F-2 alpha) and KG. Long-lasting contraction (remaining after washing away the agonist) was observed for ET-1 in RMA, but not HCMA. Constrictions to phenylephrine, U46619 or KCl did not last upon washing. When added on Lop of ET-1-initiatecl contraction in RMA, CGRP effectively counteracted vasoconstriction, i.e., it caused full relaxation. Inhibitory effects of CGRP were also observed when briefly exposing RMA and HCMA to CGRP 1 h before the addition of ET 1, Similar inhibitory effects of transient CGRP pre-incubation were seen towards phenylephrine. U46619 or KCl in RMA and HCMA. In conclusion, our data imply that CGRP, like ET-1, causes long-lasting effects that remain apparent up to 1 h after its removal horn the organ bath. Thus, in addition to the reported dissociation of ET-1/ETAR complexes, CGRP causes long-lasting non-selective arterial smooth muscle relaxation that may add to the neuropeptide being a physiological antagonist of arterial effects of ET-1. Long-lasting, washout-resistant ET-1/ETAR interaction does not occur in HCMAs. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:303 / 309
页数:7
相关论文
共 22 条
  • [1] The (pro)renin receptor blocker handle region peptide upregulates endothelium-derived contractile factors in aliskiren-treated diabetic transgenic (mREN2)27 rats
    Batenburg, Wendy W.
    van den Heuvel, Mieke
    van Esch, Joep H. M.
    van Veghel, Richard
    Garrelds, Ingrid M.
    Leijten, Frank
    Danser, Alexander H. J.
    [J]. JOURNAL OF HYPERTENSION, 2013, 31 (02) : 292 - 302
  • [2] Mediators of bradykinin-induced vasorelaxation in human coronary microarteries
    Batenburg, WW
    Garrelds, IM
    van Kats, JP
    Saxena, PR
    Danser, AHJ
    [J]. HYPERTENSION, 2004, 43 (02) : 488 - 492
  • [3] Angiotensin II type 2 receptor - Mediated vasodilation in human coronary microarteries
    Batenburg, WW
    Garrelds, IM
    Bernasconi, CC
    Juillerat-Jeanneret, L
    van Kats, JP
    Saxena, PR
    Danser, AHJ
    [J]. CIRCULATION, 2004, 109 (19) : 2296 - 2301
  • [4] Vascular actions of calcitonin gene-related peptide and adrenomedullin
    Brain, SD
    Grant, AD
    [J]. PHYSIOLOGICAL REVIEWS, 2004, 84 (03) : 903 - 934
  • [5] International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature
    Davenport, AP
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 219 - 226
  • [6] ETA-receptor antagonists or allosteric modulators?
    De Mey, Jo G. R.
    Compeer, Matthijs G.
    Lemkens, Pieter
    Meens, Merlijn J. P. M. T.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (06) : 345 - 351
  • [7] Differential Coupling of Human Endothelin Type A Receptor to Gq/11 and G12 Proteins: the Functional Significance of Receptor Expression Level in Generating Multiple Receptor Signaling
    Horinouchi, Takahiro
    Asano, Hiroshi
    Higa, Tunaki
    Nishimoto, Arata
    Nishiya, Tadashi
    Muramatsu, Ikunobu
    Miwa, Soichi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 111 (04) : 338 - 351
  • [8] BIOLOGICAL PROFILES OF HIGHLY POTENT NOVEL ENDOTHELIN ANTAGONISTS SELECTIVE FOR THE ETA RECEPTOR
    IHARA, M
    NOGUCHI, K
    SAEKI, T
    FUKURODA, T
    TSUCHIDA, S
    KIMURA, S
    FUKAMI, T
    ISHIKAWA, K
    NISHIKIBE, M
    YANO, M
    [J]. LIFE SCIENCES, 1992, 50 (04) : 247 - 255
  • [9] Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase
    MaassenVanDenBrink, A
    de Vries, R
    Saxena, PR
    Schalekamp, MADH
    Danser, AHJ
    [J]. CARDIOVASCULAR RESEARCH, 1999, 44 (02) : 407 - 415
  • [10] G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide
    Meens, M. J. P. M. T.
    Mattheij, N. J. A.
    van Loenen, P. B.
    Spijkers, L. J. A.
    Lemkens, P.
    Nelissen, J.
    Compeer, M. G.
    Alewijnse, A. E.
    De Mey, J. G. R.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (01) : 297 - 308